Signum Biosciences, Inc.
Biotechnology company · Monmouth Junction, New Jersey, United States
Signum Biosciences, Inc. is a biotechnology company headquartered in Monmouth Junction, New Jersey, United States. It has received 8 US government small-business research awards (SBIR/STTR) from health agencies, $10 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $4 million sold in a notice filed in 2011.
Signum Biosciences at a glance
What does Signum Biosciences do?
US government research funding
8 SBIR/STTR small-business research awards from US health agencies, $10.5 million in total (2008 to 2017). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $4 million sold (2011).
Frequently asked questions about Signum Biosciences
Where is Signum Biosciences headquartered?
Signum Biosciences, Inc. is headquartered in Monmouth Junction, New Jersey, United States.
What does Signum Biosciences do?
Signum Biosciences, Inc. is a biotechnology company.
Similar companies
- Elucida Oncology, Inc.Monmouth Junction, New Jersey, United States
- Pharmaseq, IncMonmouth Junction, New Jersey, United States
- Notitia Biotechnologies CoMonmouth Junction, New Jersey, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences